Delivery Order SPE2DX15D8003-SPE2DX24F7D2B
Award Date
4/8/24
Potential Completion Date
4/9/24
Potential Value
$11K
Federal Agency
Medical Supply Chain
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,857.60, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support the DLA Troop Support Medical's medical supply chain operations. The contract has a period of performance through May 30, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a Firm Fixed Price Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,624.29 contract is for the delivery of 4564885398 units of the pharmaceutical product ELIQUIS 5 MG TABLET 60S. The Delivery Order has a period of performance through June 13, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract valued at $5,205.54, awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on June 21, 2024. Dakota Drug, Inc. is a key supplier for the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $13,602.16 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 27, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense....
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $11,102.42 firm fixed-price delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on July 6, 2022. The contract is not set-aside and is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of ELIQUIS 5 MG TABLET 60S. The contract, with a ceiling value of $4,973.50 and a performance period extending through October 30, 2024, is a firm fixed-price delivery order. It is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DX15D8002|SPE2DX24F2VB1, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $6,246.23 and a period of performance through February 22, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ELIQUIS 5 MG TABLET 60S. The contract, valued at $4,840.03, has a period of performance through June 4, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,403.95, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a performance period extending through September 29, 2023 and is a firm fixed-price contract. Dakota Drug, Inc. is a key supplier to the DLA, holding a substantial Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,179.43, is for the delivery of Eliquis 5 mg tablets to support the medical supply chain operations for the U.S. Armed Forces. The contract has an ultimate completion date of April 17, 2024 and was awarded on April 16, 2024 without any set-aside designation. Dakota Drug,...